| 000 | 01330 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250514194936.0 | ||
| 264 | 0 | _c20040824 | |
| 008 | 200408s 0 0 eng d | ||
| 022 | _a0009-9236 | ||
| 024 | 7 |
_a10.1016/j.clpt.2004.04.007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLanfear, David E | |
| 245 | 0 | 0 |
_aCaution with beta1-adrenergic receptor genotyping. _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _cAug 2004 |
||
| 300 |
_a185-6; author reply 186 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Letter; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetoprolol _xadverse effects |
| 650 | 0 | 4 | _aPharmacogenetics |
| 650 | 0 | 4 | _aPolymorphism, Restriction Fragment Length |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, beta-1 _xdrug effects |
| 650 | 0 | 4 | _aRisk Assessment |
| 700 | 1 | _aMarsh, Sharon | |
| 700 | 1 | _aMcLeod, Howard L | |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 76 _gno. 2 _gp. 185-6; author reply 186 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clpt.2004.04.007 _zAvailable from publisher's website |
| 999 |
_c14990719 _d14990719 |
||